What is the address of GSK-PROJECTEN?

The registered office of GSK-PROJECTEN is located at Guffenslaan 44, 3500 Hasselt.

Is GSK-PROJECTEN still active?

Yes. According to the CBE (2 November 2026) GSK-PROJECTEN is active, legal situation “Normale toestand”, started on 31 May 2007.

Is GSK-PROJECTEN registered on Peppol?

Yes, GSK-PROJECTEN is registered on the Peppol network with ID 0208:0890187608.

What is the enterprise number of GSK-PROJECTEN?

The enterprise number of GSK-PROJECTEN is BE0890187608.

When was GSK-PROJECTEN founded?

GSK-PROJECTEN was founded on 31 May 2007.

Who are the directors of GSK-PROJECTEN?

According to the 2025 annual accounts, the directors of GSK-PROJECTEN are: Gerard Schouten.

Is GSK-PROJECTEN a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 31 May 2007; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did GSK-PROJECTEN make in 2025?

GSK-PROJECTEN posted a profit after taxes of € 1,748 in financial year 2025.

What is the revenue of GSK-PROJECTEN?

As a small company, GSK-PROJECTEN is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 12,355.

GSK-PROJECTEN (Private Limited) - Hasselt - BE0890187608

Q: What does GSK-PROJECTEN do?

GSK-PROJECTEN is registered with the CBE as active in: Ontwikkeling van residentiële bouwprojecten. Private Limited, started on 31 May 2007, 1 establishment.

Dossier GSK-PROJECTEN, printed on 2 November 2026 from databakkes.be/en/0890187608/gsk-projecten. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

GSK-PROJECTEN from Hasselt, company number BE0890187608, closed financial year 2025 with a result of € 1,748 after tax. For that financial year GSK-PROJECTEN recorded a gross margin of € 12,355 and equity of € 58,618. Compared with financial year 2024, the result moved from € 26,700 to € 1,748. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on January 30, 2026.

What it is worth Growing

€ 58,618

▲ 3% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 1,748

▼ 93% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 7,608

▼ 97% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 48,445.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 1,671

▼ 82% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 5,794

▼ 94% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 42,929 Gross margin 2022: € 42,929 First fiscal year in the series	€ 23,237 Gross margin 2023: € 23,237 ▼ 46% vs 2022 (€ 42,929) Unfavourable step	€ 63,688 Gross margin 2024: € 63,688 ▲ 174% vs 2023 (€ 23,237) Favourable step	€ 12,355 Gross margin 2025: € 12,355 ▼ 81% vs 2024 (€ 63,688) Unfavourable step	▼ 81%
Profit after taxes	€ 53,649 Profit after taxes 2022: € 53,649 First fiscal year in the series	€ 8,668 Profit after taxes 2023: € 8,668 ▼ 84% vs 2022 (€ 53,649) Unfavourable step	€ 26,700 Profit after taxes 2024: € 26,700 ▲ 208% vs 2023 (€ 8,668) Favourable step	€ 1,748 Profit after taxes 2025: € 1,748 ▼ 93% vs 2024 (€ 26,700) Unfavourable step	▼ 93%
Equity	€ 46,501 Equity 2022: € 46,501 First fiscal year in the series	€ 55,169 Equity 2023: € 55,169 ▲ 19% vs 2022 (€ 46,501) Favourable step	€ 56,870 Equity 2024: € 56,870 ▲ 3% vs 2023 (€ 55,169) Favourable step	€ 58,618 Equity 2025: € 58,618 ▲ 3% vs 2024 (€ 56,870) Favourable step	▲ 3%
Total debts	€ 175,811 Total debts 2022: € 175,811 First fiscal year in the series	€ 330,256 Total debts 2023: € 330,256 ▲ 88% vs 2022 (€ 175,811) Unfavourable step	€ 253,656 Total debts 2024: € 253,656 ▼ 23% vs 2023 (€ 330,256) Favourable step	€ 7,465 Total debts 2025: € 7,465 ▼ 97% vs 2024 (€ 253,656) Favourable step	▼ 97%
Cash	€ 3,036 Cash 2022: € 3,036 First fiscal year in the series	€ 4,011 Cash 2023: € 4,011 ▲ 32% vs 2022 (€ 3,036) Favourable step	€ 257,216 Cash 2024: € 257,216 ▲ € 253,205 vs 2023 (€ 4,011) Favourable step	€ 7,608 Cash 2025: € 7,608 ▼ 97% vs 2024 (€ 257,216) Unfavourable step	▼ 97%
Land & buildings	-	-	-	€ 3,216 Land & buildings 2025: € 3,216 First fiscal year in the series
Retained profit	€ 27,901 Retained profit 2022: € 27,901 First fiscal year in the series	€ 36,569 Retained profit 2023: € 36,569 ▲ 31% vs 2022 (€ 27,901) Favourable step	€ 46,697 Retained profit 2024: € 46,697 ▲ 28% vs 2023 (€ 36,569) Favourable step	€ 48,445 Retained profit 2025: € 48,445 ▲ 4% vs 2024 (€ 46,697) Favourable step	▲ 4%
Dividend	€ 35,000 Dividend 2022: € 35,000 First fiscal year in the series	€ 0 Dividend 2023: € 0 ▼ 100% vs 2022 (€ 35,000) Unchanged	€ 16,573 Dividend 2024: € 16,573 Unchanged (€ 0) Unchanged	€ 0 Dividend 2025: € 0 ▼ 100% vs 2024 (€ 16,573) Unchanged	▼ 100%
Bank debt	€ 125,000 Bank debt 2022: € 125,000 First fiscal year in the series	€ 231,120 Bank debt 2023: € 231,120 ▲ 85% vs 2022 (€ 125,000) Unfavourable step	€ 125,000 Bank debt 2024: € 125,000 ▼ 46% vs 2023 (€ 231,120) Favourable step	€ 0 Bank debt 2025: € 0 ▼ 100% vs 2024 (€ 125,000) Favourable step	▼ 100%
Balance sheet total	€ 222,312 Balance sheet total 2022: € 222,312 First fiscal year in the series	€ 385,425 Balance sheet total 2023: € 385,425 ▲ 73% vs 2022 (€ 222,312) Unchanged	€ 310,526 Balance sheet total 2024: € 310,526 ▼ 19% vs 2023 (€ 385,425) Unchanged	€ 66,083 Balance sheet total 2025: € 66,083 ▼ 79% vs 2024 (€ 310,526) Unchanged	▼ 79%

Key figures of GSK-PROJECTEN, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.

What happened to GSK-PROJECTEN?

What happened at GSK-PROJECTEN in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jan 30, 2026 New annual accounts for financial year 2025: profit of € 1,748 (▼ 93% vs 2024). Source: NBB ↗
2024 Gerard Schouten became a director. NBB
Aug 1, 2007 New establishment in Hasselt. KBO
May 31, 2007 Start of the company according to the CBE. KBO

In short

From € 53,649 profit in 2022 to € 1,748 profit in 2025.

Paid € 23,680 in corporate taxes since 2022.

Best year ever: 2022, with € 53,649 profit.

Paid out € 51,573 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

BS Vastgoedmanagement 50%

The stake of BS Vastgoedmanagement comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

GSK-PROJECTEN

Bouw id 50%

Behind GSK-PROJECTEN is Gerard Schouten. The shares are held by BS Vastgoedmanagement (50%). It owns 50% of Bouw id itself.

Directors

According to the 2025 annual accounts

Gerard Schouten

Director

Also active at: CS-CONTRACTING, BOUWID

since 2024

Shareholders

BS Vastgoedmanagement

50%

Participations

Bouw id

50%

Establishments

Establishment units

Physical locations of this company

Registered office

Guffenslaan 44

3500 Hasselt

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 5 companies are registered at this address.

All companies at this address →

BOUWID same network

€ -250 gross margin · 2026

GSK-Beheer

€ 155,313 gross margin · 2025

GSK INVESTMENT COMPANY

€ 221,848 gross margin · 2025

BRIC architectuur

€ 43,738 gross margin · 2025

TERRA NOVA

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0890.187.608

VAT number

BE 0890.187.608

Registered office

Guffenslaan 44, 3500 Hasselt

Names & denominations

GSK-PROJECTEN

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

31 May 2007

Peppol

Active · Active since 19 Jan 2026

Activities · NACE

Ontwikkeling van residentiële bouwprojecten

Projectontwikkeling voor woningbouw

Verhuur en exploitatie van eigen of geleased residentieel onroerend goed, exclusief sociale woningen

Verhuur en exploitatie van eigen of geleased niet-residentieel onroerend goed, exclusief terreinen

Ontwikkeling van niet-residentiële bouwprojecten

Activiteiten van adviesbureaus op het gebied van public relations en communicatie

Handel in eigen onroerend goed

Public relationsbureaus

View on CBE Public ↗ Annual accounts (NBB) ↗

GSK-PROJECTEN

Financials

What happened to GSK-PROJECTEN?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions